GTG signs 3-year US licence agreement for COVID risk test

Melbourne, Australia, 3 March 2021:Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), adiversified Genomics and AI driven preventative health business is pleased to announce a co-exclusiveproduction and distribution rights and license agreement (‘Agreement’) with US Based Infinity BiologiX LLC(‘IBX’), a leading central laboratory providing sample collection and processing, st